- Genetic Embryo Testing
PGT-A Testing in Multan
PGT-A (Preimplantation Genetic Testing for Aneuploidy) checks embryos for the correct number of chromosomes during your IVF cycle. Unlike PGD or general chromosomal screening, PGT-A is built specifically to catch aneuploidies — the chromosome-count abnormalities most closely linked to implantation failure and miscarriage.
Eggs are retrieved and fertilised as in a standard IVF cycle, grown to the blastocyst stage, and a small number of cells are safely biopsied for analysis. Only embryos with a normal chromosome count are then considered for transfer.
Targets Aneuploidy Directly
Built specifically to catch chromosome-count abnormalities in embryos.
Lowers Miscarriage Risk
Chromosomally normal embryos are markedly less likely to result in loss.
Sharper Embryo Selection
Helps your specialist choose the single embryo most likely to succeed.
- The Procedure
How PGT-A fits into your IVF cycle
PGT-A runs alongside the IVF process you’re already going through, adding one careful extra check before transfer.
1
Egg Retrieval & Fertilisation
Eggs are retrieved and fertilised, as in a standard IVF cycle.
2
Blastocyst Culture
Embryos are grown in the lab to the blastocyst stage.
3
Cell Biopsy & Analysis
A few cells are safely biopsied and analysed for chromosome count.
4
Healthy Embryo Transfer
Only embryos with a normal chromosome count are selected for transfer.
- Why It Matters
Who should consider PGT-A testing
PGT-A makes the biggest difference for couples in specific situations. It’s worth discussing with your fertility specialist if any of these apply:
Advanced Maternal Age
Women aged 35 or older, where chromosomal risk rises naturally with age.
Recurrent Failure or Loss
Repeated IVF failure or recurrent pregnancy loss with no clear cause.
Severe Male Factor Infertility
Where sperm-related factors raise the odds of chromosomal issues in embryos.
Improving Overall Success Rates
Anyone wanting to raise the odds of a successful transfer, regardless of history.
- COMMON QUESTIONS
Frequently Asked Questions
It’s a test done during IVF that checks the number of chromosomes in an embryo before it’s chosen for transfer.
PGT-A specifically screens for aneuploidies — chromosome-count abnormalities that are closely linked to implantation failure and miscarriage.
A small number of cells are carefully removed from each embryo at the blastocyst stage and analysed for chromosome count.
Women of advanced maternal age, couples with recurrent IVF failure or miscarriage, those with severe male factor infertility, or anyone looking to improve IVF success rates.
PGS was the earlier term for chromosomal screening. PGT-A is the more precise, modern version, checking all chromosomes to identify the healthiest embryo for transfer.
No test can guarantee pregnancy, but PGT-A significantly improves the odds by selecting embryos with a normal chromosome count.
PGT-A is highly accurate at detecting chromosomal abnormalities, making it a dependable tool for embryo selection.